In addition, other complications during ICU such as AKI, liver injury, and secondary fungal infection were lower than the control; however, these results did not reach statistical significance ( Table 3 ).
← all excerpts
The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study.
1
—
—